PharmaZell Overview

  • Founded
  • 1946

Founded
  • Status
  • Private

  • Employees
  • 2,000

Employees
  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 6

  • Investments
  • 3

PharmaZell General Information

Description

Developer of active pharmaceutical ingredients (API) and natural source materials intended for blue-chip pharmaceutical companies. The company offers a focused portfolio of small molecule APIs combined with custom development and manufacturing services for the generic and originator pharmaceutical industry.

Contact Information

Formerly Known As
ZellBios
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Discovery Tools (Healthcare)
Primary Office
  • Rosenheimer Strauße 43
  • 83064 Raubling
  • Germany
+49 08035 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaZell Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PharmaZell‘s full profile, request access.

Request a free trial

PharmaZell Patents

PharmaZell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3875596-A1 Method for hydroxylation of steroids Pending 06-Mar-2020 0000000000
EP-3875597-A1 Method for hydroxylation of steroids Pending 06-Mar-2020 000000000
EP-3849965-A1 A process for the preparation of ozanimod and its intermediate (s)-1-amino-2,3-dihydro-1h-indene-4-carbonitrile Pending 12-Sep-2018 0000000000
AU-2019338657-A1 A process for the preparation of ozanimod and its intermediate (s)-1-amino-2,3-dihydro-1h-indene-4-carbonitrile Pending 12-Sep-2018 0000000000
CA-3109673-A1 A process for the preparation of ozanimod and its intermediate (s)-1-amino-2,3-dihydro-1h-indene-4-carbonitrile Pending 12-Sep-2018 C07D271/06
To view PharmaZell’s complete patent history, request access »

PharmaZell Executive Team (15)

Name Title Board Seat Contact Info
Sylke Hassel Ph.D Chief Executive Officer
Edgar Lange Chief Financial Officer
Mario Giacomo Chief Operating Officer, Europe
Anant Barbadikar Chief Operating Officer, India
Ester Masllorens Ph.D Chief Technology Officer
You’re viewing 5 of 15 executive team members. Get the full list »

PharmaZell Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaZell Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PharmaZell‘s full profile, request access.

Request a free trial

PharmaZell Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 16-Sep-2021 0000000000 BPO/Outsource Services 00000 000
000000000 18-Oct-2011 0000000000 Biotechnology
GEA Pharmaceutical 12-Jul-2007 Buyout/LBO Pharmaceuticals
To view PharmaZell’s complete investments history, request access »

PharmaZell Subsidiaries (2)

Company Name Industry Location Founded
Farmabios Biotechnology Luxembourg, Luxembourg 2011
0000000 BPO/Outsource Services Lyon, France 0000
To view PharmaZell’s complete subsidiaries history, request access »